VIII CONGRESSO SINV (Societą Interdisciplinare NeuroVascolare) RAPALLO (GE) 26-27 Novembre 1999

The Multidisciplinary approach to the ischaemic cerebrovascular pathology

"THE QUANTITATIVE DISPLAY OF CARDIAC AND CEREBROVASCULAR RISK FACTORS:
PRACTICAL CONSIDERATIONS REGARDING THE COMPUTERIZATION IN PRIMARY PREVENTION"

Francesco Piruzza, General Practitioner, A.S.S. no. 4 "Medio Friuli", Castions di Strada, UDINE, ITALY

Scientific research has identified and quantified risk factors basing itself on results of random trials on a vast scale. In reality, however, the doctor has the difficulty of quantifying the individual risk for one specific patient and chosing the preventive pharmacological treatment on a long term basis, which should be all based on the evaluation of the probable benefit related to the reduction of this risk.
A practical instrument for the quantification and the display of the risk has been achieved by the researchers of the Canadian Medical Association: the researchers after having re-elaborated the data from the Framingham Study gave a score to the various risk factors and have inserted them into two gradient charts.(see James McCormack, Pharm D;Levine,; Rangn. Primary prevention of heart disease and stroke: a simplified approach to estimating risk of event and making drug treatment descisions. CMAJ 1997; 157:422-8)

PROCEDURE:

1)Consult the chart with the PAS, col-tot, HDL, smoke, diabetes, IVS, FA scores. 2)Single out the patient's age on the scale for men and women. 3) Trace a vertical line which intersects the relative risk curve. The value on the y-axis corresponds to the risk only according to age and sex. 4) In order to add the other risk factors, identify the value for each risk factor. If the number is positive move the previously identified point towards the right according to the number of spaces indicated by the final number, towards the left if the number is negative.
The percentage of risk evaluation is purely indicative since it doesn't take other factors such as family history, sendentary way of life and body weight into account. In spite of these limits the method remains a valid one for primary prevention.
The procedure is quite simple but rather laborious: for obvious logistic reasons, the practical application in the GP's studio proves to be far from easy.
The author has computerized the Canadian researcher's methods inserting bars into the original charts which automatically show the percentage of risk and, with the aid of a paticular device, displays the benefits in risk reduction, after a period of time, produced by preventive therapeutical measures. Furthermore, he has elaborated another chart to identify the level of risk regarding the BMI (chart no. 3) and an accompanying analysis of other risk factors so as to obtain a more meaningful prognostic value.
The software has been set out on one screen so as to have an overall picture of the patient's problems thus translating the important and innovative concept of "GLOBAL RISK" proposed by the Task Force for Prevention of Coronary Heart Disease in cooperation with the Atherosclerosis Society. (Nutrition 1998): it stresses the importance of considering all the known variables as a whole in order to distinguish the cardiovascular risk profile in each individual.
Since a number of preset factors can coexist in the same person, in this case, they can interact multiplying the cardiovascular risk and this obviously has a particular importance in determining the prognosis, the choice of an appropriate therapy andthe desirable levels to reach for the reduction of the risk factors.

The Boolean data processing automatically gives a detailed report:
a) of the patient's risk in percentage in 5 and 10 years,
b) the diagnosis of the risk level (slightly increased, moderately increased or elevated)according to the global risk criteria published by Nutrition.
c) of the alterable F.R.,
d) of the therapeutical and/or diagnostic measures to adopt,
e) the print-out of a report, for the patient's use, to make him aware of his own responsabilities with regards to the risk factors.

 

EVIDENCE-BASED-MEDICINE

There are NON Modifyable risk factors ( age, sex, family history and race) and Modifyable risk factors ( diabetes, hypertension, peripheral vascular diseases, smoke, alcohol, obesity, a sedentary way of life, cholesterol, hyperuricemia, prothrombotic factors, hyperomocystinemia, menopause, PCR, personality type, stress, migrane, CHD, IVS, F. arterial and socio-environmental situations.)
Here is an example that describes the above : consider a 50 year-old man, 1,75m tall, weighing 95Kg (IMC=31), smoker, with PAS 160 mmHg, Col-tot 292 mg/dl, HDL 33 mg/dl, non-diabetic and without IVS electrocardiographic signals.
His cardiovascular risk is 13% in 5 years and 23% in 10 years. After 6 months' diet and the changes in life-style the physical and ematochemical values have been normalized: (IMC=27, PAS 135 mmHg, Col-tot 200 mg/dl, HDL 48 mg/dl, smoking forbidden).
His cardiovascular risk has diminished sensibly in 5 and 10 years positioning itself in the lower most part of the risk curve.

Absolute risk and Relative risk

According to the Framingham Study, about 17% of the vascular events in men are represented by heart attack or death caused by coronary heart disease, while in women the percentage increases to 40%. Therefore, returning to our previous example, the patient's risk in a 5 year period of myocardio heart attack or death due to coronary heart disease is 9.1% (70% of 13%) and at 10 years 16.10%.
The risk of cardiovascular events in 10 years can be calculated the same way using the second chart. After adding up all the risk factors, the percentage of absolute risk for the same patient is equal to 12%. According to the Framingham Study, the ischaemic attacks represent about 25% (20% for women) of the cerebrovascular events. Therefore, this patient has a 9% probability of being the victim of a fatal or non-fatal stroke in the next 10 years.

The strong point of the evaluation, apart from reducing the under-estimation of the risk factors and the potential beneficial therapies, is definitely the support given to evidence-based-medicine.

The computerization of the method, removing the logistic problems (ease of use and rapid execution) would allow the wide-scale use in GP's studios: primary prevention would become routine and one could automatically have a constantly up-dated map of the patients with a high risk factor at one's disposal, together with the consequent positive implications regarding the rationalization of the resources

 

 Home

 

ć 1999 Copyright Piruzza dr. Francesco

Castions di Strada ( UD)

Italia Tutti i diritti riservati